FDA Advisers Vote Against Avastin for Advanced Breast Cancer Treatment

In three unanimous votes, the six members of the FDA oncology drug panel voted that Avastin is ineffective, unsafe and should have its approval for breast cancer treatment withdrawn, citing…

More in Health >